magrolimab,azacitidine
gilead sciences
['azacitidine,(-oral azaci),(-azacitidine oral)', 'leukemia', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops)', 'magrolimab']
congress #asco22 | talks about the results of a phase ib study of magrolimab + azacitidine in patient with tp53 mutated aml. (n = 72). cr was achieved in 33.3% of patients with half of these being mrd-ve. orr was 48.6% #leusm #leukemia 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm